The original success of the copyright undeniably reshaped the pharmaceutical landscape, but placing funds in companies strongly reliant on generic versions presents a complex picture. While early earnings were impressive, the expiration of patents and the emergence of discounted alternatives have eroded the customer base. Therefore, a thorough a… Read More